Skip to main content
. 2022 Feb 2;20:61. doi: 10.1186/s12967-022-03252-7

Table 4.

The logistic regression analysis of efficacy prediction for serum inflammation indexes in ESCC receiving anti-PD1 plus chemotherapy

OR (95% CI) P value
LMR at baseline
  ≤ 3.173 1.00
  > 3.173 3.881E8 (0.000-) 0.998
S II at post treatment of second period
  ≤ 174.574 1.00
  > 174.574 9.563E8 (0.000-) 0.999
PLR at post treatment of third period
  ≤ 151.516 1.00
  > 151.516 0.083 (0.009–0.782) 0.030